Skip to content

Released Aug 6, 2018, after the close

10-Q filed Aug 6, 2018, 37 days after period end · 0001564590-18-019507

Q2 2018 · 10-Q
Revenue$111.55M+2.4% vs Q2 2017+2.6% vs Q1 2018
Net Income$925.00K−76.0% vs Q2 2017−82.3% vs Q1 2018
EPS Diluted$0.05−76.2% vs Q2 2017−81.5% vs Q1 2018
Gross Profit$88,712,000+3.4%
Operating Income$5,915,000−26.0%
Operating Cash Flowderived$16,592,000+165.2%
Free Cash Flowderived$13,641,000+363.5%
Margins · derived
Gross margin79.5%+0.8 pt vs Q2 2017
Operating margin5.3%−2.0 pt vs Q2 2017
Net margin0.8%−2.7 pt vs Q2 2017

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2018Q2 2017Q2 2016Q2 2015
Revenue$111.55M$108.94M$104.08M$100.95M
Net Income$925.00K$3.85M-$7.44M$3.57M
EPS Diluted$0.05$0.21-$0.41$0.19

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR